Su Zhen
Karyopharm Therapeutics Inc. · Director
Su Zhen is listed in public filings as director. This Su Zhen insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Karyopharm Therapeutics Inc. (KPTI), and CytomX Therapeutics, Inc. (CTMX). Investors use Su Zhen's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --15.5k shares | Grant / ExerciseMay 21, 2026 | Disclosure amount unavailable15.5k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $107k38k shares | Grant / ExerciseJun 11, 2025 | $107.2K38k shares | $2.82 | -- | |
| $21k4.6k shares | Grant / ExerciseMay 28, 2025 | $20.6K4.6k shares | $4.48 | -- |